Suraksha Diagnostic enterprise value

·Pharma & HealthChart ›
MultiplesEnterprise valuePer share
Share price at each year-end
Tap a line for its trendCurrentlast 12MFY26Mar 2026FY25Mar 2025
1,664——
3.23.22.2
−1.4−1.4−1.0
1.71.75.8
1,661——
−1.5−1.53.6
₹319.00——
245245216
0.7%0.7%2.7%
0.00×——
5.10×——
16.27×——
28.24×——
114.70×——
Reference items — trailing FY values
325310252
10295.481.2
58.853.945.9
—81.863.4
14.514.521.3
—14.421.2
—67.342.0
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

SURAKSHA₹319.55

Suraksha Diagnostic Limited

· Pharma & Health
₹ CrorePeersKRSNAAHEALTHXNEPHROPLUS3BBLACKBIOMcap ₹1,664 Cr
HighlightsEnterprise ValueMultiplesPer ShareAnnuals · FY-end closes
In ₹ Crore except Per Share
12 Months Ending
FY25
31/03/2025
FY26
31/03/2026
Current/LTM
TTM · last close
Market Capitalization——1,664.2
- Cash, Equiv & ST Investments2.23.23.2
+ Minority Interest-1.0-1.4-1.4
+ Total Debt5.81.71.7
Enterprise Value——1,661.4
Net Debt (memo)3.6-1.5-1.5
EV per Share——319.00
Total Capital216.1245.2245.2
Total Debt/Total Capital2.700.710.71
Total Debt/EV——0.00
EV/Sales——5.10
EV/EBITDA——16.27
EV/EBIT——28.24
EV/Free Cash Flow——114.70
Reference Items — Trailing FY Values
Sales252.1310.4325.5
EBITDA81.295.4102.1
EBIT45.953.958.8
Operating Cash Flow63.481.8—
Free Cash Flow21.314.514.5
FCFF (free cash flow to the firm)21.214.4—
Capital Expenditure42.067.3—
Market Cap/EV/multiples pair each (split/bonus-adjusted) FY-end close with the latest filed share count; Current column uses the last close. Market Capitalization is a market-level figure — identical across Consolidated/Standalone (the accounting rows below differ). No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.